Melanoma News and Research

Latest Melanoma News and Research

Surgery studies show progress, opportunity to decrease opioid prescribing

Having surgery means placing complete trust in a team of professionals, and counting on them to fix what's wrong while keeping surgical risks as low as possible.

11 Nov 2020

Researchers propose a non-invasive, accurate method for melanoma detection

A team of researchers from Kaunas University of Technology and Lithuanian University of Health Sciences proposed a non-invasive method for detection of melanoma.

10 Nov 2020

A new method to improve the preclinical evaluation of CAR T cell therapies

Ludwig Cancer Research scientists have developed a method to significantly improve the preclinical evaluation of chimeric antigen-receptor (CAR) T cell therapies, in which the immune system's T cells are extracted from a patient, engineered to target a specific tumor-associated molecule and then grown and reinfused for cancer treatment.

6 Nov 2020

Older men are underdiagnosed and undertreated for osteoporosis

A new study reveals that many older men who experience a fracture are still underdiagnosed with and undertreated for osteoporosis.

6 Nov 2020

Researchers develop novel chemo-immunotherapy agent to treat pancreatic tumors

Pancreatic cancer is highly lethal: according to the National Cancer Institute, only about 10 percent of patients remain alive five years after diagnosis.

6 Nov 2020

Repurposing an anxiety drug to increase the efficacy of therapies for metastatic melanoma

There are times when adding something new to the mix makes it better. Give Popeye some spinach, and you've got a fighting machine. Give Mario a mushroom, and he becomes invincible. Without drinking a potion, Alice in Wonderland would never fit through the door.

5 Nov 2020

Immunotherapy side effect could signal improved control of kidney cancer

An autoimmune side effect of immune checkpoint inhibitor (ICI) drugs could signal improved control of kidney cancer, according to a new study by researchers in UT Southwestern's Kidney Cancer Program (KCP).

2 Nov 2020

Two studies find age as a primary factor in melanoma treatment resistance

Age may cause identical cancer cells with the same mutations to behave differently. In animal and laboratory models of melanoma cells, age was a primary factor in treatment response.

2 Nov 2020

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.

30 Oct 2020

Researchers report a novel approach to generate T-cells faster

Adoptively transferred T-cells can prolong survival and sometimes cure patients with advanced solid tumors. While promising, it can take months to generate the necessary T-cells to help these patients. Such slow speed makes this therapy impractical for most patients who need immediate treatment.

30 Oct 2020

"Training" the immune system with β-glucan compound may improve immune recovery

Immunotherapies, such as checkpoint inhibitor drugs, have made worlds of difference for the treatment of cancer.Most clinicians and scientists understand these drugs to act on what's known as the adaptive immune system, the T cells and B cells that respond to specific threats to the body.

30 Oct 2020

Research details new strategy for overcoming treatment resistance by zeroing in on dendritic cells

Many of the most aggressive and hard-to-treat cancers are highly effective at blocking T cells, known as the foot soldiers of the immune system, from reaching and responding to tumors.

27 Oct 2020

Scientists identify new therapeutic targets for SARS-CoV-2

To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a genome-scale, loss-of-function CRISPR screen to systematically knockout all genes in the human genome.

27 Oct 2020

Age can affect response to adjuvant treatment among patients with resected melanoma

Younger patients with resected melanoma had some benefit from adjuvant treatment with the anti-VEGF therapeutic bevacizumab (Avastin) while older patients with resected melanoma did not

23 Oct 2020

Scientists may be able to prevent cancer by controlling the ANP32E and H2AZ proteins

Someday, scientists may be able to prevent cancer by controlling two proteins that operate deep inside the quagmire of epigenetic cell fate transitions, a new paper suggests.

21 Oct 2020

Study findings may help identify new targets to inhibit spread of melanoma

Research led by Queen Mary University of London has revealed novel insights into the mechanisms employed by melanoma cells to form tumors at secondary sites around the body.

20 Oct 2020

UCLA professor named to the National Academy of Medicine

Dr. Antoni Ribas, a world-renowned physician-scientist and professor of medicine at the David Geffen School of Medicine at UCLA, has been named to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.

19 Oct 2020

Key blood marker can lead to effective melanoma treatments

An Edith Cowan University (ECU) study has revealed that a key blood marker of cancer could be used to select the most effective treatment for melanoma.

16 Oct 2020

Moffitt study uncovers how specific molecules promote cancer progression

The development of cancer is a highly complicated process, involving multiple genes and signaling pathways that become upregulated or downregulated throughout different stages of tumor growth and spread.

15 Oct 2020

Neoadjuvant trial of combination immunotherapy has favorable outcomes in bladder cancer patients

Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.

13 Oct 2020

Melanoma News and Research

Latest Melanoma News and Research

Surgery studies show progress, opportunity to decrease opioid prescribing

Researchers propose a non-invasive, accurate method for melanoma detection

A new method to improve the preclinical evaluation of CAR T cell therapies

Older men are underdiagnosed and undertreated for osteoporosis

Researchers develop novel chemo-immunotherapy agent to treat pancreatic tumors

Repurposing an anxiety drug to increase the efficacy of therapies for metastatic melanoma

Immunotherapy side effect could signal improved control of kidney cancer

Two studies find age as a primary factor in melanoma treatment resistance

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

Researchers report a novel approach to generate T-cells faster

"Training" the immune system with β-glucan compound may improve immune recovery

Research details new strategy for overcoming treatment resistance by zeroing in on dendritic cells

Scientists identify new therapeutic targets for SARS-CoV-2

Age can affect response to adjuvant treatment among patients with resected melanoma

Scientists may be able to prevent cancer by controlling the ANP32E and H2AZ proteins

Study findings may help identify new targets to inhibit spread of melanoma

UCLA professor named to the National Academy of Medicine

Key blood marker can lead to effective melanoma treatments

Moffitt study uncovers how specific molecules promote cancer progression

Neoadjuvant trial of combination immunotherapy has favorable outcomes in bladder cancer patients

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Melanoma News and Research

Latest Melanoma News and Research

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in